MDQK.HM MediNavi AG (HAM) up 200.00% 20 Jan 2026: low-volume spike demands careful review
MDQK.HM stock surged 200.00% to €7.50 on 20 Jan 2026, a large price move after the stock opened at €2.50. The jump occurred on only 35 shares, below the average volume of 41. This price action makes MediNavi AG (MDQK.HM) a high-volume mover by percentage, not by traded shares, and it signals sharp short-term volatility for traders and investors.
Market move and volume context for MDQK.HM stock
MediNavi AG (MDQK.HM) moved from €2.50 to a day high of €7.50 on 20 Jan 2026. The percentage gain of 200.00% contrasts with an absolute volume of 35 shares. That mix—big price swing and thin liquidity—raises execution and price-discovery risks for any order larger than a few hundred shares.
Fundamentals and financial metrics for MDQK.HM stock
Public data show limited operating metrics: trailing EPS and P/E are None and market cap reports 0.00. Key balance ratios include a current ratio of 41.50 and interest coverage of -1,362.59, reflecting negligible operating scale and interest strain. Enterprise value is listed as -255,031.00, and EV/EBITDA is 2.17, but these figures appear distorted by minimal liquidity and reporting gaps.
Technical, liquidity and trading profile for MDQK.HM stock
Short-term indicators are unreliable on sparse trades: ATR registers 5.00, RSI is 0.00, and Keltner Channel middle sits at 7.50. The 50-day average price is €2.50 and the 200-day average is €2.00, both far below today’s €7.50. Traders should treat intraday fills as potentially unrepresentative of supply and demand.
Meyka AI grade and model view on MDQK.HM stock
Meyka AI rates MDQK.HM with a score of 58.60 out of 100, grade C+ and suggestion HOLD. This grade factors S&P 500 and sector comparisons, industry metrics, financial growth, key ratios, forecasts, analyst consensus, and fundamental growth. The score flags moderate structural weakness and limited public reporting.
Meyka AI’s forecast and valuation for MDQK.HM stock
Meyka AI’s forecast model projects a 12-month fair value of €3.25 versus the current price of €7.50, implying a downside of -56.67%. Forecasts are model-based projections and not guarantees. Given the spike from €2.50 to €7.50, the model treats the current price as an outlier and prefers a conservative fair value.
Risks, catalysts and sector context for MDQK.HM stock
Key risks include low liquidity, opaque reporting, and no public EPS or scheduled earnings. Catalysts that could restore confidence are audited releases, a transparent revenue update, or new user growth at the MediNavi platform. The healthcare sector in Germany shows YTD performance of 1.49%, but MDQK.HM moves are idiosyncratic and not sector-driven.
Final Thoughts
MDQK.HM stock’s 200.00% price spike to €7.50 on 20 Jan 2026 is a high-percentage mover driven by extremely light volume. Our review finds sparse public financials, a distorted enterprise value, and unreliable technical signals because trades are thin. Meyka AI’s model projects a 12-month fair value near €3.25, implying -56.67% from today. That forecast reflects price mean-reversion toward the 50-day average €2.50 and 200-day average €2.00. Short-term traders may profit from volatility, but institutional investors should demand clearer financial disclosures before adding MDQK.HM to a portfolio. For real-time monitoring and order execution considerations, see MediNavi’s site and our Meyka stock page for MDQK.HM updates MediNavi website and Meyka MDQK.HM page. Forecasts are model-based projections and not guarantees.
FAQs
What caused the MDQK.HM stock jump on 20 Jan 2026?
The jump to €7.50 appears driven by a few aggressive trades and not public earnings. Volume was 35 shares, below the 41 average. Thin liquidity amplified price moves without clear fundamental catalysts.
How reliable is valuation data for MDQK.HM stock?
Valuation is unreliable because EPS and market cap report as missing or zero. Key ratios like current ratio 41.50 and EV/EBITDA 2.17 likely reflect accounting quirks rather than normal operating scale.
What does Meyka AI forecast say for MDQK.HM stock?
Meyka AI’s forecast model projects €3.25 as a 12-month fair value versus €7.50 now, implying -56.67%. The model warns the current price is an outlier caused by thin trading.
Should investors trade MDQK.HM stock after this spike?
Active traders can use tight stops and limit orders because volatility is high. Long-term investors should wait for audited results, higher liquidity, and clearer revenue reports before investing.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
